G. Beran

Transcriptional pathway signatures predict MEK addiction and response to selumetinib (AZD6244).

B. Taylor, N. Hayward, C. Pratilas, 2010, Cancer research.

Subtypes of primary colorectal tumors correlate with response to targeted treatment in colorectal cell lines

G. Orphanides, L. Wessels, A. Schlicker, 2012, BMC Medical Genomics.